Mar 24, 2026

Email 1:

Subject: The High-Stakes Search for a New CDC Director

Sender: newsletter@statnews.comD

Summary:

Jonathan Wosen reports on the complex search for a new permanent CDC director under the Trump administration, emphasizing the need for a candidate with high moral integrity and expertise to lead the agency. The director’s position is currently vacant, with acting director Jay Bhattacharya’s term ending soon. About six candidates are being considered. Meanwhile, Robert F. Kennedy Jr. challenges existing vaccine policies but recently faced a federal court injunction. Also covered are topics on AI worsening medicine’s trust problem, stricter FDA rules complicating fecal transplants for C. diff infection, immigration policy’s impact on international medical students’ residency matches, and worsened diabetes outcomes related to insurance loss.

Key Points:

– Vaccine policy changes by RFK Jr. blocked by court; administration undecided on appeal.

– CDC director search ongoing; trust in CDC has declined over time.

– AI in medicine faces trust issues, especially among marginalized patients.

– New FDA rules restrict stool transplants, complicating treatment access.

– International medical students face declining residency match rates due to immigration hurdles.

– Insurance instability worsens diabetes management.

Email 2:

Subject: 🤖 Digital Medicine’s Moments

Sender: vitals@axios.comD

Summary:

Axios Vitals explores the evolving integration of AI-powered digital therapies with prescription medicine, highlighting challenges in assessing effectiveness and regulatory issues. AI apps assist in chronic disease and mental health management, potentially easing workforce shortages. The Trump administration narrows CDC director candidates amid leadership vacancies. Additionally, federal audits reveal inappropriate use of antipsychotic drugs in nursing homes to manage dementia behavior, with facilities lacking proper safeguards. Hospitals’ revenue increasingly comes from diversified sources beyond patient care.

Key Points:

– AI therapies blur lines between drug and digital intervention; regulatory clarity needed.

– FDA approved AI virtual assistants for post-surgery recovery and apps for depression since 2024.

– Nursing home audits show misuse of antipsychotics and improper diagnoses to inflate ratings.

– CDC director search includes candidates like Ernie Fletcher and Joseph Marine; acting director term ending.

– Hospitals generate much revenue beyond direct patient care (e.g., grants, philanthropy).

Email 3:

Subject: We’ve Just Had the 11 Hottest Years on Record

Sender: briefing@nature.comD

Summary:

Nature reports that 2015-2025 constitutes the hottest decade on record, with rising Earth’s energy imbalance and unprecedented atmospheric CO2 levels. The newsletter highlights advances including bioengineered oesophagus transplants in pigs, progress toward nuclear clocks using thorium-229, and skepticism about AI’s purported intelligence. It discusses redefining economic prosperity beyond GDP and evidences sperm whales engaging in headbutting behavior. A personal account is shared from an atmospheric scientist surviving a tornado.

Key Points:

– Climate crisis deepens with record high temperatures and CO2 concentrations.

– Stem cell–grown oesophagi restore pig swallowing, promising less invasive human treatments.

– Nuclear clocks expected soon, offering unprecedented precision.

– AI ‘intelligence’ is a human-designed tool, not true cognition.

– Alternative measures to GDP seek to better capture economic wellbeing.

Email 4:

Subject: Save the Date | Axios Future of Health Summit Returns to DC on May 13

Sender: events@axios.comD

Summary:

Axios announces the 2026 Future of Health Summit taking place in Washington, D.C., on May 13. The event will convene health care executives, lawmakers, and experts to discuss affordability, biotech breakthroughs, AI developments, and health care policy amid an election year. It aims to explore challenges at the intersection of innovation, access, and cost control in health care.

Key Points:

– Summit date: May 13, 2026, 1:30pm – 7:00pm ET, in Washington, D.C.

– Focus on health care affordability and innovation including biotech and AI.

– Event gathers stakeholders during a politically charged election year.

Email 5:

Subject: The Lineup is Taking Shape — Early Access Extended

Sender: marketing@statnews.comD

Summary:

STAT announces the extension of early access registration for the STAT Breakthrough Summit West, scheduled for May 19 in San Francisco and online. Early Access pricing is available through April 1, offering savings. The summit will feature discussions on AI and drug development. Confirmed speakers include Ted W. Love, Anne Wojcicki, Neil Kumar, Jacqueline Poot, Joe Betts-LaCroix, and Zachary Ziegler.

Key Points:

– Early Access registration extended to April 1 with savings up to $300.

– Event date: May 19, 2026, in San Francisco or online.

– Speakers include biotech leaders and innovators in AI and pharma.

Stay Well!